Xolair subcutaneous injection 75mg pen (YJ code: 2290400G3024, standard: 1 kit of 0.5mL 75mg) is a Novartis Pharma product containing Omalizumab (genetical recombination). It is used to control severe allergic asthma symptoms in adults, adolescents, and children (6 years and older), as well as to treat chronic rhinosinusitis with nasal polyps in adults.
Xolair subcutaneous injection 75mg pen
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).